Biological
IVIG (Intravenous Immunoglobulin)
IVIG (Intravenous Immunoglobulin) is a biological therapy with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_3
1
25%
Ph phase_2
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Active, not recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)
Trials by Status
active_not_recruiting125%
completed250%
recruiting125%
Recent Activity
2 active trials
Showing 4 of 4
completednot_applicable
Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.
NCT07532707
recruitingphase_3
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
NCT06742190
active_not_recruitingphase_2
RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)
NCT06305793
completedphase_2
A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
NCT00194987
Clinical Trials (4)
Showing 4 of 4 trials
NCT07532707Not Applicable
Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.
NCT06742190Phase 3
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
NCT06305793Phase 2
RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)
NCT00194987Phase 2
A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4